Tick-borne Encephalitis and Borrelial Antibodies in Serum

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2014

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Tick Borne Encephalitis
Interventions
DRUG

Doxycycline

Beside symptomatic therapy, patients will receive oral Doxycycline 100 mg, Doxy® twice daily.

DRUG

Symptomatic therapy

Patients will receive symptomatic therapy with antipyretics, analgetics, antiemetics, and parenteral hydration: metamizole, Analgin®, paracetamol, Lekadol®, thiethylperazine, Kytril®, saline. Questionnaire Subjects will be asked to answer a questionnaire asking about the presence and frequency of nonspecific symptoms such as headache, fatigue, arthralgia, myalgia.

OTHER

Questionnaire

Subjects will be asked to answer a questionnaire asking about the presence and frequency of nonspecific symptoms such as headache, fatigue, arthralgia, myalgia.

Trial Locations (1)

Unknown

RECRUITING

University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
collaborator

University of Ljubljana School of Medicine, Slovenia

OTHER

lead

University Medical Centre Ljubljana

OTHER